Patents Examined by David J. Blanchard
  • Patent number: 10806683
    Abstract: Disclosed are perfume compositions containing perfume ingredients selected on the basis that they are able to be stably incorporated into core-shell microcapsules. Perfume selection rules are based on a molecular descriptor of the electron density distribution within a perfume ingredient—RECON VOLTAE. Perfume ingredients having known RECON_VOLTAE values larger than about 1200 Bohr3, more particularly larger than 1540 Bohr3, and more particularly still larger than about 1750 Bohr3 are particularly suitable for encapsulation.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: October 20, 2020
    Assignee: GIVAUDAN SA
    Inventors: Christian Quellet, Andras Borosy
  • Patent number: 10806688
    Abstract: The present invention is directed to a method of achieving improved hair volume comprising applying to hair a composition comprising from about 0.25% to about 80% of a pre-emulsified emulsion comprising from about 0.005% to about 80% of one or more materials selected from the group comprising metathesized unsaturated polyol esters, sucrose polyesters, fatty esters with a molecular weight greater than or equal to 1500 and mixtures thereof or, by weight of said hair care composition; wherein an emulsifier is selected from the group consisting of anionic, non-ionic, cationic, amphoteric and mixtures thereof wherein the average particle size of the pre-emulsified emulsion is from about 20 nanometers to 20 microns; from about 5% to about 50% of one or more anionic surfactants, by weight of said hair care composition; from about 0.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: October 20, 2020
    Assignee: The Procter and Gamble Company
    Inventors: Qing Stella, Eric Scott Johnson, Sean Michael Renock, Michael Stephen Maile, Michael Frederick Niebauer, Stephanie Lyn Siemer
  • Patent number: 10799441
    Abstract: The present invention relates to cosmetic or dermatological compositions containing PQQ or its esters, methods of treating or promoting skin changes by topical application of these compositions, and methods of synthesis of PQQ esters. The PQQ ester-containing compositions of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the PQQ esters of the present invention have an antioxidant effect that is useful in treating a skin change.
    Type: Grant
    Filed: June 5, 2012
    Date of Patent: October 13, 2020
    Assignee: PCR TECHNOLOGY HOLDINGS, LC
    Inventors: Joseph Abernathy Lewis, II, Joseph C. DiNardo
  • Patent number: 10780053
    Abstract: This invention provides methods for producing a polymer particle which contains unusually high negative charges on the surface of the particle. Preferably, the polymer is pharmaceutically acceptable. The negative charges can be conferred by chemical groups such as carboxyl, sulfonate, nitrate, fluorate, chloride, iodide, persulfate, and many others, with carboxyl group being preferred. The invention also provides polymer particle produced by the methods of the invention.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: September 22, 2020
    Assignee: Phosphorex, Inc.
    Inventor: Bin Wu
  • Patent number: 10765613
    Abstract: A lotion emulsion composition comprising a preservative enhancing agent and a rheology modifier, wherein the preservative enhancing agent comprises one of sorbitan caprylate, glyceryl caprylate/caprate, or a combination thereof, the rheology modifier comprises a hydrocolloid, the pH of the lotion emulsion composition is less than about 4.2, and the combined amount of preservative enhancing agent and rheology modifier is less than about 0.3% by weight of the total lotion emulsion composition.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: September 8, 2020
    Assignee: The Procter & Gamble Company
    Inventor: Randall Glenn Marsh
  • Patent number: 10758025
    Abstract: The present invention relates to a two-compartment aerosol device, comprising a styling composition in a first compartment and a compressed gas chosen from air, nitrogen and carbon dioxide, and mixtures thereof, in a second compartment. Said styling composition comprises at least one compound (A) chosen from an anionic carboxylic polymer free of urethane units, a linear sulfonic polyester and a cellulose-based compound in an alcoholic or aqueous-alcoholic medium which comprises at least 5% by weight, relative to the weight of said composition, of a C1-C4 monohydric alcohol. This aerosol device may constitute a hair lacquer. The invention also relates to a styling process using the device of the invention.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: September 1, 2020
    Assignee: L'OREAL
    Inventors: Francois Le Bourhis, Jonathan Gawtrey
  • Patent number: 10758546
    Abstract: The present invention provides a transdermal delivery system, which comprises a drug-containing matrix layer comprising: galantamine or its pharmaceutically acceptable salt as an active ingredient; and a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: September 1, 2020
    Assignees: Industry-Academic Cooperation Foundation, TAHO Pharmaceuticals Ltd.
    Inventors: Hoo-kyun Choi, Myung-kwan Chun
  • Patent number: 10744097
    Abstract: The present invention is directed to an immediate release and extended release capsule or capsule fill which mitigates the abuse of abuse-susceptible active pharmaceutical ingredients by direct intravenous injection. The fill comprises a parenteral abuse resistant liquid formulation which when mixed with water and heated, results in a turbid, viscous or bubbling mixture that is not injectable with a standard insulin syringe. The abuse-susceptible active pharmaceutical ingredient is selected from the group consisting of opiates, opioids, tranquillizers, stimulants and narcotics.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: August 18, 2020
    Assignee: R.P. Scherer Technologies, LLC
    Inventor: Simone Wengner
  • Patent number: 10736835
    Abstract: The present disclosure relates to a sprayable gel composition for hair conditioning, comprising (a) from about 0.01% to about 0.35% by weight of an acrylate/alkyl-acrylate cross-polymer, (b) from about 0.1% to about 30% by weight of a silicone oil selected from dimethylpolysiloxane, cyclic polysiloxanes, hydroxyl-terminated polydimethylsiloxanes, polysiloxane-polyalkylene copolymers, alkyl methyl polysiloxanes, phenylmethylpolysiloxane, hydroxyl-terminated polydimethylsiloxanes, divinyldimethicone/dimethicone copolymer, and combination thereof, (c) from about 0.1% to about 30% by weight of a monohydric alcohol containing from about 2 to about 8 carbon atoms, and (d) from about 40% to about 99.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: August 11, 2020
    Assignee: Henkel AG & Co. KGaA
    Inventors: Yi Shi, Xiaowei Chang
  • Patent number: 10736838
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: August 11, 2020
    Assignee: Emplicure AB
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Petterson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • Patent number: 10729128
    Abstract: The present invention relates in general to a medical device consisting of a blocker made of a mixture of natural products such as African palm oil and the triglycerides thereof and natural waxes as active and emulsifying components, polymer and silver nanoparticles, acting as a blocker for latex protein and other skin irritants.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: August 4, 2020
    Assignee: BIOTD SOCIEDAD ANÖNIMA
    Inventors: Robin A. Wiscovitch, Juan Valdes Gonzalez, Roy Mora Gonzaga
  • Patent number: 10722461
    Abstract: The present disclosure is broadly concerned with petrolatum-based compositions as a suspension matrix for the active ingredients. The disclosure is also concerned with processes for forming stable emulsions of active ingredients in petrolatum.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: July 28, 2020
    Assignee: GLOBAL HEALTH SOLUTIONS, LLC
    Inventor: Bradley Burnam
  • Patent number: 10722446
    Abstract: Described herein are aqueous oral care compositions comprising (a) an effective amount of a basic amino acid in free or orally acceptable salt form; and (b) a polymer system comprising (i) a cellulosic polymer, (ii) a gum polymer, and (iii) a polyacrylate polymer or co-polymer; and methods of making and using the same.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: July 28, 2020
    Assignee: Colgate-Palmolive Company
    Inventors: Paloma Pimenta, Davide Miksa, Shira Pilch, Aarti Rege, Richard Sullivan
  • Patent number: 10716746
    Abstract: The present disclosure relates to a sprayable gel composition, comprising (a) from about 0.08% to about 1.8% by weight of a polysaccharide, (b) from about 0.002% to about 0.08% by weight of a divalent alkaline earth cation, (c) from about 0.1% to about 30% by weight of a humectant, (d) from 0% to about 30% by weight of an emollient, and (e) from about 40% to about 95% by weight of a cosmetically acceptable carrier, wherein the weight percentages are based on the total weight of all components of the sprayable gel composition, and to a method of treating hair in need of a conditioning treatment.
    Type: Grant
    Filed: December 25, 2015
    Date of Patent: July 21, 2020
    Assignee: Henkel AG & Co. KGaA
    Inventors: Yi Shi, Xiaowei Chang
  • Patent number: 10716765
    Abstract: Functional ingredients including an esterified component and microencapsulated in an enteric matrix to increase the microencapsulation efficiency and reduce undesired organoleptic properties of the microencapsulated material while providing a desired release rate and ester hydrolysis rate, the process including forming an emulsion in water and titrating the emulsion with a precipitating agent to produce a particulate precipitate.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: July 21, 2020
    Assignee: Intercontinental Great Brands LLC
    Inventors: Anilkumar Ganapati Gaonkar, Les Lawrence, Ahmad Akashe, Amado R. Lopez, Ronald L. Meibach, Dana Sebesta, Yan Wang, James D. White, Leslie G. West
  • Patent number: 10702584
    Abstract: The present invention provides a method for preparing a bone protein preparation which contains for example growth factors. The present invention also provides a bone protein preparation obtained by the method and paste, putty, pellet, disc, block, granule, osteogenic device or pharmaceutical composition containing said bone protein preparation.
    Type: Grant
    Filed: June 27, 2011
    Date of Patent: July 7, 2020
    Assignee: BBS-BIOACTIVE BONE SUBSTITUTES OYJ
    Inventors: Hanna Tölli, Juha-Matti Närhi, Harri Lumme, Elli Birr, Oili Hietala, Mikko Viitanen, Merja Haikola, Pekka Jalovaara, Bo Kenneth Sandström
  • Patent number: 10695289
    Abstract: A medical device comprising a composition comprising a therapeutically active amount of active agent, a zinc compound, and an array of microneedles. The zinc compound may be selected from the group consisting of zinc, pharmaceutically acceptable salts of zinc, and mixtures thereof. At least a portion of the composition is present as a coating on at least a portion of the microneedles. Methods of delivering a therapeutically active agent to a mammal using compositions of the disclosure are also included.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: June 30, 2020
    Assignee: 3M Innovative Properties Company
    Inventors: Kenneth E. Brown, Daniel M. Dohmeier, Joan T. Moseman, Ying Zhang, Alan Harris, Gary Hattersley, Lisa A. Dick
  • Patent number: 10695290
    Abstract: A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: June 30, 2020
    Assignee: A. EBBIE SOROUDI, M.D., M.S., A PROFESSIONAL MEDICAL CORPORATION
    Inventor: A. Ebbie Soroudi
  • Patent number: 10675243
    Abstract: The disclosure provides stable formulations of cationic biocides that are primarily used in the treatment and prevention of infections. The disclosure is also concerned with processes for forming stable emulsions of cationic biocides and petrolatum.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: June 9, 2020
    Assignee: GLOBAL HEALTH SOLUTIONS LLC
    Inventor: Bradley Burnam
  • Patent number: 10675376
    Abstract: Novel absorbable polymer blends are disclosed. The blends are useful for manufacturing medical devices having engineered degradation and breaking strength retention in vivo. The blends consist of a first absorbable polymeric component and a second absorbable polymeric component. The weight average molecular weight of the first polymeric component is higher than the weight average molecular weight of the second polymeric component. At least at least one of said components is at least partially end-capped by a carboxylic acid group. Further aspects are medical devices made therefrom.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 9, 2020
    Assignee: Ethicon LLC
    Inventors: Modesto Erneta, Daniel Steiger, Dennis D. Jamiolkowski